Corporate News     05-Dec-24
Eugia Pharma Specialities receives USFDA approval for Pazopanib Tablets 200mg

Aurobindo Pharma announced that its wholly owned subsidiary company, Eugia Pharma Specialities, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Pazopanib Tablets, 200 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Votrient Tablets, 200 mg, of Novartis Pharmaceuticals Corporation. The product is expected to be launched in Q4FY25. The approved product has an estimated market size of US$ 106 million for the twelve months ending October 2024, according to IQVIA.

This is the 179 th ANDA approval (including 8 tentative approvals received) out of Eugia Pharma Specialities Group (EPSG) facilities, manufacturing both oncology oral and sterile specialty products.

Pazopanib Tablets, 200 mg is indicated for the treatment of adults with Advanced Renal Cell Carcinoma (RCC), and Advanced Soft Tissue Sarcoma (STS) who have received prior chemotherapy.

Previous News
  Auro Pharma Q3 PAT slides 10% YoY to Rs 846 crore
 ( Hot Pursuit - 07-Feb-25   12:47 )
  Aurobindo Pharma consolidated net profit declines 9.66% in the December 2024 quarter
 ( Results - Announcements 07-Feb-25   07:32 )
  Board of Aurobindo Pharma approves acquisition of 26% stake in a solar energy company
 ( Corporate News - 06-Feb-25   20:22 )
  Board of Aurobindo Pharma approves acquisition of 80% stake in Tergene Biotech
 ( Corporate News - 06-Feb-25   20:19 )
  Apitoria Pharma's Unit 2 completes USFDA inspection
 ( Corporate News - 28-Jan-25   12:15 )
  Aurobindo Pharma Ltd rises for third straight session
 ( Hot Pursuit - 20-Jan-25   13:06 )
  Aurobindo Pharma to table results
 ( Corporate News - 17-Jan-25   18:01 )
  Aurobindo Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 08-Jan-25   13:35 )
  Aurobindo Pharma Ltd up for third straight session
 ( Hot Pursuit - 31-Dec-24   13:05 )
  CuraTeQ Biologics receives UK MHRA approval for oncology biosimilar Bevqolva
 ( Corporate News - 23-Dec-24   16:13 )
  Auro Pharma gets UK MHRA nod for cancer drug
 ( Hot Pursuit - 21-Dec-24   15:20 )
Other Stories
  TT Group and AFCOM Cargo strengthen partnership for expansion of air freight services
  11-Feb-25   19:49
  Ramco Systems implements its Payce platform at Air Niugini
  11-Feb-25   19:47
  Juniper Hotels Board approves acquisition of Jenipro Hotels
  11-Feb-25   19:44
  Zaggle Prepaid Ocean Services to acquire 16.67% stake in Mobileware
  11-Feb-25   19:34
  Hatsun Agro Product further invests Rs 10 lakh in Milk Mantra Dairy
  11-Feb-25   19:31
  Borosil Scientific grants 14.08 lakh stock options under ESOS
  11-Feb-25   19:29
  Delhivery allots 8.22 lakh equity shares under ESOP
  11-Feb-25   19:28
  Apollo Pipes invests Rs 2.58 cr in Kisan Mouldings
  11-Feb-25   19:21
  Kesar India acquires 51% stake in Kesar IM Infra Projects
  11-Feb-25   19:19
  Edelweiss Financial Services allots 7.44 lakh equity shares under ESAP
  11-Feb-25   19:18
Back Top